Pfizer Inc. - Pfizer Analyst and Investor Call to Review Amended U.S. Government Paxlovid Supply Agreement and Updated Full-Year 2023 Guidance

Pfizer Analyst and Investor Call to Review Amended U.S. Government Paxlovid Supply Agreement and Updated Full-Year 2023 Guidance

10/16/2023 8:00 AM ET

Transcript (opens in new window)